ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023

ViewRay, Inc. (NASDAQ: VRAY) announced details for its upcoming conference call scheduled for February 27, 2023, at 4:30 p.m. ET, where it will discuss its fourth quarter 2022 financial results.

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) announced details for its upcoming conference call scheduled for February 27, 2023, at 4:30 p.m. ET, where it will discuss its fourth quarter 2022 financial results. Interested parties can join the call via a provided dial-in number and access a live webcast on the investor relations page of ViewRay's corporate website. The MRIdian® MR-Guided Radiation Therapy System is the company's primary product, designed specifically for advanced radiation oncology, addressing significant clinical challenges. Further information will be available after the live session on their website.

Positive

• Upcoming conference call to discuss fourth quarter 2022 financial results indicates transparency and engagement with investors.

Negative

• None.

Argus Session date unavailable

+3.85% session move Open Argus

Details

News Market Reaction – VRAY

The recorded move for VRAY in the trading session of this news was +3.85%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, Jan. 31, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of fourth quarter 2022 financial results.

ViewRay will hold a conference call to discuss results on Monday, February 27, 2023 at 4:30 p.m. ET. The dial-in numbers are (888) 396-8049 for domestic callers. The confirmation number is 47314692. A live webcast of the conference call will be available on the investor relations page of ViewRay's corporate website at https://investors.viewray.com/events-and-webinars.

After the live webcast, a replay will remain available online on the investor relations page of ViewRay's website, under "Events and Webinars".

About ViewRay®

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/viewray-announces-conference-call-for-fourth-quarter-2022-financial-results-to-be-held-after-market-on-february-27-2023-301734321.html

SOURCE ViewRay, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will ViewRay announce its fourth quarter 2022 financial results?

ViewRay will announce its fourth quarter 2022 financial results on February 27, 2023.

What time is the ViewRay conference call scheduled for?

The ViewRay conference call is scheduled for 4:30 p.m. ET on February 27, 2023.

How can I access the ViewRay conference call?

You can access the ViewRay conference call by dialing (888) 396-8049 for domestic callers.

Where can I find the webcast of the ViewRay conference call?

The live webcast of the ViewRay conference call can be found on the investor relations page of ViewRay's corporate website.